EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

PROSTALUBAN - A NOVEL REMEDY FOR BENIGN PROSTATE HYPERPLASIA

Dr. Luay Rashan, Dr. Mohammed Rishan and Dr. Rafie Hamidpour*

ABSTRACT

Benign prostatic hyperplasia also called prostate gland enlargement, is a non-malignant enlargement hyperplasia, is one of the most common diseases in ageing men, which can lead to lower urinary tract symptoms. An enlarged prostate gland can cause uncomfortable urinary symptoms, such as blocking the flow of urine out of the bladder. It can also cause bladder, urinary tract or kidney problems. It can also cause bladder, urinary tract or kidney problems. The prevalence of BPH increases after the age of 40 years, with a prevalence of 8%-60% at age 90 years. Although the exact cause is unknown, however, the prevalence of benign prostatic hyperplasia depends on many factors such as, age, race, hormones, persistent inflammation, genetics, lifestyle, bacterial infection, obesity. Recent reports suggest the strong relationship of clinical BPH with metabolic syndrome and erectile dysfunction. A wide variety of treatments are available for enlarged prostate, including medication, minimally invasive therapies and surgery. Among medications there are two main medication classes for benign prostatic hyperplasia management , these are the alpha-blockers and 5α-reductase inhibitors. On the other hand, there are also natural remedies that may work to combat enlarged prostate symptoms such as using saw palemetto, stinging nettle, beta-sitosterols and others. However, the evidence is debatable on whether these treatments actually work, and research continues to look into a multi-targeted and multi-channel molecule with potential anti-inflammatory activity that modulate several targeting properties. ProstaLuban is a novel synergistic composition that combines potentially multi targeted well-researched standardized extract from Omani frankincense Boswellia sacra oleaogum resin with other know researched ingredients such as pygeum, saw palemetto extracts, nettle extracts and zinc oxide. This product is significantly better as an anti-inflammatory agent compared with other available natural remedies.

Keywords: .


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 February 2020 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2020 Issue has been successfully launched on 1 February 2020.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing